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Tendinopathy in 55 Dogs:  
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Sherman O. Canapp Jr.1*, Debra A. Canapp1, Victor Ibrahim2, Brittany Jean Carr1, 
Catherine Cox1 and Jennifer G. Barrett3
1 Veterinary Orthopedic and Sports Medicine, Annapolis Junction, MD, USA, 2 Regenerative Orthopedic and Sports Medicine, 
Washington, DC, USA, 3 Marion duPont Scott Equine Medical Center, Virginia-Maryland College of Veterinary Medicine, 
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Objective: To report clinical findings and outcomes for 55 dogs with supraspinatus 
tendinopathy (ST) treated with adipose-derived progenitor cells and platelet-rich plasma 
(ADPC-PRP) therapy.
Methods: Medical records of client-owned dogs diagnosed with ST that were treated 
with ADPC-PRP combination therapy were reviewed from 2006 to 2013. Data collected 
included signalment, medical history, limb involvement, prior treatments, physical and 
orthopedic examination, objective temporospatial gait analysis findings, diagnostic
imaging results (radiography, magnetic resonance imaging, musculoskeletal ultrasonog-
raphy), arthroscopy findings, and outcome.
results: Following ultrasound-guided injection of ADPC-PRP, objective gait analysis 
was available on 25 of the 55 dogs at 90  days post ADPC-PRP therapy. Following 
treatment, a significant increase in total pressure index percentage (TPI%) was noted in 
the injured (treated) forelimb at 90 days post treatment (p = 0.036). At 90 days following 
treatment, 88% of cases had no significant difference in TPI% of the injured limb to the 
contralateral limb. The remaining 12% of cases had significantly improved (p = 0.036). 
Bilateral shoulder diagnostic musculoskeletal ultrasound revealed a significant reduction 
in tendon size (CSA) in the treated tendon at 90 days following treatment when compared 
to the initial CSA (p = 0.005). All cases showed significant improvement in fiber pattern 
of the affected supraspinatus tendon by the ultrasound shoulder pathology rating scale.
clinical relevance: These findings suggest that ADPC-PRP therapy should be con-
sidered for dogs with ST.
 
Keywords: supraspinatus tendinopathy, mesenchymal stem cells, platelet-rich plasma, adipose-derived stem 
cells, regenerative medicine, rotator cuff
Abbreviations: ADPC, adipose-derived progenitor cells; MSC, mesenchymal stem cells; PRP, platelet-rich plasma; ST, 
supraspinatus tendinopathy; TPI%, total pressure index percentage.
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inTrODUcTiOn
Supraspinatus tendinopathy (ST) is a common cause of forelimb 
lameness in dogs. The etiology of ST is thought to be repeated 
strain activity and overuse from chronic repetitive activity, with 
a failure of adequate remodeling (1–4). As in humans, it can be 
challenging to treat and recurrence is not uncommon. While 
inflammation may play a role in the initiation of ST, it generally 
is not involved in the propagation and progression of the disease 
process. Histology of pathologic supraspinatus tendons shows 
either absent to minimal inflammation with hypocellularity, 
a loss of tightly bundled collagen appearance, an increased 
proteoglycan content, and a lack of neovascularization in 
response to injury (4–13). Tendons damaged from repeated 
strain demonstrate discontinuous, disorganized tendon fib-
ers with little to no inflammation, occasional mineralization 
within the tendon, and bony remodeling at its insertion site in 
chronic cases (5, 12). In chronic cases, calcification at the site 
of insertion has been well documented in both humans and 
dogs (8, 13–16).
Diagnostic musculoskeletal ultrasonography is a relatively 
new technique that has been used and validated for the diagnosis 
of ST in both humans and dogs (1, 17–24). Musculoskeletal 
ultrasound provides a non-invasive definitive diagnosis of ST, 
and allows for facile and cost-effective sequential examinations 
to assess response to treatment. Changes in size, shape, and 
echogenicity of the tendon found on diagnostic ultrasound all 
may indicate ST (25).
Previous reports on the treatment of ST in dogs have 
included both conservative and surgical management (26–30). 
While both surgical management and conservative manage-
ment have been reported for treatment of ST in dogs, up to 55% 
of surgically treated dogs and in up to 33% of non-surgically 
treated dogs have persistence or recurrence of lameness (26, 27). 
Regarding conservative medical management, our retrospective 
study on 327 ST cases in dogs revealed 75% failed to respond 
to rest and non-steroidal anti-inflammatory drugs and 40% 
failed to respond to a dedicated rehabilitation therapy program 
(30). Recent studies have suggested the potential efficacy of 
biologic regenerative therapies in humans (31, 32). One recent 
study in which a single platelet-rich plasma injection for ST was 
performed in 10 dogs showed a subjective (owner-assessed) 
improvement in lameness and function in 40% of dogs with 
improved tendon heterogenicity and in 60% of dogs with 
improved echogenicity (33). However, to the authors’ knowl-
edge no studies have evaluated the use of stem cell therapy in 
treating ST in dogs.
Mesenchymal stem cells (MSC) found in bone marrow and 
adipose tissue can differentiate into multiple cell lines, including 
bone, cartilage, and fibrous connective tissue, such as tendons 
(34). In addition, MSC cells secrete cytokines and growth fac-
tors that reduce inflammation, inhibit programmed cell death 
in the cells within the tissue, recruit circulating stem cells to 
the area, and integrate and remodel the tissue through a well 
described paracrine effect (35). Meta-analysis of MSC effects on 
tendon healing suggests that stem cells increase collagen fiber 
density, enhance tissue architecture, restore a nearly normal 
tendon–bone interface, and improve biomechanical strength 
(36). In addition to the effects of MSCs on tendons, there is 
evidence demonstrating that MSCs survive when extracted 
and placed into the tendon environment and that cells can be 
stored for later use. Although the evidence for use of stem cells in 
tendons remains limited due to low clinical trial data, dozens of 
pre-clinical studies strongly support its potential role in tendon 
healing (37).
Mesenchymal stem cells have potent anti-inflammatory, anti-
fibrosis, pro-angiogenic properties, and can integrate into ten-
don tissue and contribute to healing (38). MSCs require growth 
factor supplementation for growth in vitro, and the tendinopathy 
environment may not allow for optimal MSC cell growth and 
integration. Moreover, MSCs prefer to connect into a three-
dimensional fibrous environment (39). PRP can provide both 
growth factors to promote MSC engraftment, as well as a fibrin 
scaffold for MSCs to attach to upon injection and platelet activa-
tion. PRP has been shown to release its growth factors 5 days after 
activation, while MSCs have been demonstrated to survive at the 
injection site at least 30 days after injection, thus giving both an 
early and sustained stimulus for healing (39). Synergy between 
stem cells and PRP has been reported (40–42). Certain growth 
factors and cytokines released from platelets bind to receptors on 
the surface of stem cells and initiate a cascade involving signal 
transduction, gene expression and stem cell proliferation, migra-
tion, and differentiation. In addition, PRP provides a delivery 
vehicle and three-dimensional scaffold to support cell survival 
and proper differentiation (43). For these reasons, platelet-rich 
plasma combination therapy together with MSCs was used in 
this study.
The purpose of this retrospective study was to describe the 
effects of adipose-derived progenitor cells and platelet-rich 
plasma (ADPC-PRP) combination therapy for the treatment of 
ST in dogs.
MaTerials anD MeThODs
Dogs
In accordance with AAALAC International Rules of Accreditation, 
this study was performed with the approval of the VOSM 
Research Committee and with owner consent. All clients volun-
teered their dog for the study and provided written consent as 
required by Veterinary Orthopedic and Sports Medicine Group 
for every study participant. Medical records of client-owned dogs 
diagnosed with ST that were treated with ADPC-PRP combina-
tion therapy were reviewed from 2006 to 2013. Data collected 
included signalment, history, limb involvement, prior treatments, 
physical and orthopedic examination, objective temporospatial 
gait analysis findings, diagnostic imaging results [radiography, 
magnetic resonance imaging (MRI), musculoskeletal ultrasonog-
raphy], arthroscopy findings, presence of concurrent shoulder 
and elbow pathologies, treatments administered, and outcome. 
Dogs were excluded from this study if there was the presence of 
concurrent orthopedic or neurological disease, recommended 
treatment and therapy plans were not adhered to, or if follow-up 
information was not available.
3Canapp Jr. et al. Regenerative Medicine for Supraspinatus Tendinopathy
Frontiers in Veterinary Science | www.frontiersin.org September 2016 | Volume 3 | Article 61
Orthopedic evaluation
All patients were evaluated with an orthopedic and neurological 
evaluation at baseline as well as follow-up at 30, 60, and 90 days 
post treatment. Shoulder range of motion in flexion, extension, 
and abduction were recorded. Discomfort was noted if found on 
shoulder manipulation or direct palpation of the supraspinatus. 
All other abnormal orthopedic or neurological findings were also 
recorded.
Diagnostic imaging
Radiography
Routine lateral and craniocaudal radiographs were performed of 
both shoulders and elbows in all patients at baseline. All radio-
graphs were evaluated for evidence of shoulder and/or elbow 
pathology by a board certified veterinary surgeon.
Magnetic Resonance Imaging
Magnetic resonance imaging was recommended for all patients. If 
elected, patients were placed under general anesthesia and images 
of the affected shoulder were acquired using a 1.5-T MRI. All 
images were reviewed by a board certified veterinary radiologist.
Musculoskeletal Ultrasonography
Bilateral shoulder musculoskeletal diagnostic ultrasound was 
performed at baseline and at 45 and 90  days post treatment. 
Bilateral shoulder musculoskeletal diagnostic ultrasonographic 
measurements for each dog were performed using Sonosite Edge 
musculoskeletal ultrasound machine with a 15-6  MHz linear 
probe. Patients were placed in lateral recumbency, and both 
shoulder areas were clipped and cleaned. Sedation or anesthesia 
was not required. Ultrasonographic images of the supraspinatus 
tendon of both limbs, including transverse and longitudinal 
images, were obtained (Figures 1 and 2). Supraspinatus muscle 
depth was measured at the level of the proximal acromion to 
evaluate atrophy. The supraspinatus tendon cross-sectional area 
(CSA) was measured in the transverse plane in three images/
tendon.
gait analysis
Objective gait analysis was performed at baseline as well as 
follow-up at 90 days post treatment. Objective gait analysis was 
performed in a quiet room using a temporospatial pressure 
sensing walkway. The walkway system was equipped with a 
8.23 m × 0.85 m portable mat containing 29,952 encapsulated 
sensors.1 The active dimensions of the mat were 8.04 m × 0.61 m. 
A 1.25 m × 0.85 m section of inactive mat was placed at each 
end of the walkway system to provide transition surfaces when 
entering and exiting the system. The mat was calibrated by the 
manufacturer. The walkway system interfaced with a computer 
and software program for processing and storage of raw data 
recorded from quadruped gait analysis.2 One camera was posi-
tioned at a height of 50  cm at the end of the walkway system 
1 GaitFour Pressure Sensing Walkway, platinum version, CIR Systems Inc., 
Harvertown, PA, USA.
2 GaitFour, platinum version, CIR Systems Inc., Harvertown, PA, USA.
to record movement.3 Digital video files of each pass across the 
walkway system were automatically linked to the data files for 
footfall verification.
Every dog was handled by the same examiner and allowed to 
acclimate to the room prior to data collection. Dogs were walked 
on the mat until they appeared relaxed (~4–6 passes/dog). Three 
passes across the walkway were recorded at both the walk and the 
trot. A pass was defined as a dog moving along the length of the 
portable walkway system in one direction and consisted of 4–6 
gait cycles. Inclusion criteria for a pass were that the dog was at a 
walk (velocity, 0.9–1.2 m/s) or a trot (velocity, 1.8–2.6 m/s), had 
minimal head turning, and that gait cycle velocities did not vary 
by more than 10%. The first three passes that met the inclusion 
criteria were analyzed for each dog. Videos of each pass were 
reviewed to ensure that all inclusion criteria were met.
The software program was used to identify the paw print of 
each footfall. The software program then performed analysis of 
multiple variables for each pass. Data gathered or calculated from 
each pass provided the total pressure index percentage (TPI%) for 
each foot (the sum of peak pressure values recorded from each 
activated sensor by a paw during mat contact/total sum of peak 
pressure values for all feet × 100) (44). The TPI% of the injured 
limb was compared to the contralateral limb TPI% at baseline and 
at follow-up at 30, 60, and 90 days post treatment.
Diagnostic elbow and shoulder 
arthroscopy
Diagnostic elbow and shoulder arthroscopy was performed to 
rule out the presence of concurrent intra-articular pathology. 
A standard medial portal was utilized for arthroscopic evalua-
tion of the elbow. Following routine aseptic preparation of the 
elbow, a 22-gage needle was placed into the elbow in the medial 
compartment. Synovial fluid was aspirated using a 5-ml syringe 
to ensure the needle was in the joint. Approximately 5  ml of 
saline was then injected into the elbow to distend the joint. 
A 15 blade was used to create a stab incision through the skin 
to allow for insertion of the cannula and trochar into the elbow. 
The 1.9-mm arthroscope was then inserted into the cannula. 
Arthroscopic evaluation was performed to confirm no signs of 
pathology.
A standard lateral portal was utilized for arthroscopic evalu-
ation of the affected shoulder. Following aseptic preparation, a 
22-gage needle was placed into the shoulder. Synovial fluid was 
aspirated using a 5-ml syringe to ensure that the needle was in 
the joint. Approximately 5–10 ml of saline was then injected into 
the shoulder to distend the joint. A 15 blade was used to create a 
stab incision through the skin to allow for insertion of the can-
nula and trochar into the shoulder. The 1.9-mm arthroscope was 
then inserted into the cannula. The shoulder was then assessed 
without the fluid pump activated in order to observe the joint 
in a more natural environment without significant distension. 
This would allow for identification of a supraspinatus bulge. The 
biceps, subscapularis tendon, MGL, joint capsule, and cartilage 
were observed to confirm no evidence of pathology.
3 Logitech MP web camera, Logitech, Freemont, CA, USA.
FigUre 2 | The longitudinal diagnostic musculoskeletal ultrasound image of the supraspinatus tendon (white arrow).
FigUre 1 | The transverse diagnostic musculoskeletal ultrasound image of the supraspinatus tendon (white outline).
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Falciform collection for aDPc Processing
Patients were pre-medicated with 0.1 mg/kg hydromorphone 
intramuscularly, 0.2  mg/kg midazolam intramuscularly, and 
0.5  mg/kg famotidine subcutaneously. General anesthesia 
was induced using intravenous propofol to affect. The abdo-
men was clipped and aseptically prepared for surgery. A 4-cm 
incision was made in midline in the cranial abdomen. A 2-cm 
incision was made through the linea. The falciform ligament 
was identified. Approximately 20  g of falciform adipose tis-
sue was collected and placed into a sterile container with 
Delbecco’s modified Eagle’s medium (DMEM) supplemented 
with fetal bovine serum (FBS), penicillin, and streptomycin. 
FigUre 3 | Ultrasound guidance was used to administer aDPc-PrP therapy with a fenestration technique. A 22-gage needle was inserted along the 
long axis of the supraspinatus tendon (red arrow), parallel to the ultrasound transducer. Once the needle was identified in the plane, the needle was advanced into 
the tendon lesion.
TaBle 1 | Patient breed.
Breed number of patients
Basenji 1
Bernese Mountain Dog 2
Border Collie 13
Boxer 3
Corgi 3
German Shepherd Dog 7
Golden Retriever 3
Greater Swiss Mountain Dog 1
Labrador Retriever 13
Mixed Breed 5
Poodle – Standard 1
Rhodesian Ridgeback 1
Rottweiler 1
Wheaton Terrier 1
TaBle 2 | Patient occupation.
Occupation % of patients
Agility 37
Field trial 7.4
Flyball 7.4
Herding 7.4
Hunting 3.7
Obedience 18.5
Rally 7.4
Show 11.1
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The sample was then prepared for shipment. A routine closure 
was performed.
Blood collection for PrP Processing
The jugular vein was clipped and aseptically prepared. 
Approximately 30  ml of blood was collected using an 18-gage 
butterfly needle into a syringe with 5 ml of CPDA anti-coagulant. 
The sample was then prepared for shipment.
aDPc and PrP Processing
Adipose and blood samples were shipped in validated contain-
ers at 4°C to Virginia Tech’s Regenerative Medicine Research 
Laboratory for processing as per US patent application number 
#62050792. Adipose was processed using established techniques 
(45). The tissue was mechanically and enzymatically separated to 
release ADPCs. The cells were then washed in phosphate-buffered 
saline (PBS) and nucleated cells were counted and cultured in 
stem cell media at 37°C in a 5% CO2 incubator with 95% humid-
ity. Adherent cells were monitored daily for adherence, growth, 
and phenotype. Once 70% confluent, these first passage cells 
were detached from the flasks, washed in PBS, and suspended in 
autologous PRP.
Platelet-rich plasma was prepared from anti-coagulated blood 
via centrifugation first for 10 min at 800 g, then the platelet-rich 
supernatant above the buffy coat was centrifuged at 4,000 ×  g 
for 10 min and the pellet was resuspended in plasma to obtain 
a three- to fourfold increase in platelets and 80–90% reduction 
in white blood cells over whole blood. Platelet and white blood 
cell counts were performed for each sample to confirm appro-
priate concentrations prior to use, and prepared in 1-ml dose/
tendon with 5 million ADPCs/milliliter. ADPC-PRP was then 
shipped back to VOSM for injection at 4°C using validated ship-
ping containers.
FigUre 4 | (a) Shoulder radiograph with mineralization of the supraspinatus tendon insertion (red arrow); (B) STIR sagittal image of a shoulder MRI in a patient with 
a supraspinatus tendinopathy showing an inflamed supraspinatus tendon; (c) STIR transverse image of a shoulder MRI in a patient with a supraspinatus 
tendinopathy showing a flattened or oval appearance of the biceps tendon and loss of fluid around the biceps tendon within the bicipital groove at the level of 
insertion of the supraspinatus; (D) T1 MRI image in a patient with a supraspinatus tendinopathy showing fatty replacement at the myotendinous junction of the 
supraspinatus tendon; (e) diagnostic musculoskeletal shoulder ultrasound image depicting an enlargement of the supraspinatus tendon.
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FigUre 5 | The total pressure index percentage (TPi%) of the affected 
limb in individual patients at days 0 and 90.
FigUre 6 | results of objective gait analysis showed a significant 
difference in total pressure index percentage (TPi%) between the 
injured and contralateral normal forelimb at day 0 (p = 0.014). There 
was no significant difference in total pressure index percentage (TPI%) 
between the injured and contralateral normal forelimb at day 90.
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Ultrasound guidance of aDPc-PrP 
Therapy
Ultrasound guidance was used to administer ADPC-PRP therapy 
with a fenestration technique (46, 47). Patients were sedated 
using 0.05 mg/kg of dexdomitor and 0.2 mg/kg of butorphanol 
intravenously. The shoulder was clipped and aseptically prepared. 
A 22-gage, 1.5″ needle was inserted along the long axis of the 
tendon, parallel to the ultrasound transducer. Once the needle 
was identified in the plane, the needle was advanced into the 
tendon lesion. As the needle was slowly passed into the lesion and 
withdrawn, ADPC-PRP was injected into the lesion (Figure 3). 
Proper placement and delivery of the ADPC-PRP was monitored 
continuously using ultrasound guidance.
Post Treatment rehabilitation Therapy
All patients were enrolled in rehabilitation therapy follow-
ing ADPC-PRP therapy. For the first 8  weeks, each patient 
participated in once weekly manual/massage therapy, class IIIb 
low-level laser therapy for the affected shoulder (5  J/cm2), and 
a twice daily at home exercise program. Additionally, at 8 weeks 
following treatment, patients were allowed to start hydrotherapy 
with underwater treadmill. No NSAIDs, corticosteroids, class IV 
low-level laser therapy, therapeutic ultrasound, or TENS/NMES 
were permitted at any time during the first 8  weeks, nor were 
any of these treatments required during the remaining recovery 
period in any of the patients.
statistics
Statistical analysis of CSA over time and TPI over time was per-
formed using repeated measures ANOVA with post hoc Tukey’s 
test. Significance was set at P < 0.05.4
resUlTs
Patient Demographics
Medical records of 55 dogs diagnosed with unilateral ST treated 
with ADPC-PRP therapy were reviewed. Age ranged from 1 to 
14 years (average 6.4 years, median 6 years). No sex predisposi-
tion was apparent with 26 female dogs (1 intact) and 29 male dogs 
(2 intact). There were 13 Border Collies, 13 Labrador Retrievers, 
7 German Shepherd Dogs, 5 Mixed Breed Dogs, 3 Boxer Dogs, 
3 Welsh Corgis, 3 Golden Retrievers, 2 Bernese Mountain Dogs, 
and 1 of each of the following: Basenji, Greater Swiss Mountain 
Dog, Standard Poodle, Rhodesian Ridgeback, Rottweiler, and 
Wheaton Terrier (Table 1). Occupation was evenly split between 
companion dog and performance/sporting dog at 50.1 and 49.1%, 
respectively (Table 2). Duration of lameness ranged from 1 week 
to over 1 year. A majority of dogs, 61.8%, had previously failed 
to respond to non-steroidal anti-inflammatory drugs and 45.5% 
also failed rehabilitation therapy. Of the performance/sporting 
dogs, 96.4% of them returned to sport after 4 months following 
ADPC-PRP therapy.
4 GraphPad Prism 6, GraphPad Software Inc., La Jolla, CA, USA.
radiographs
Routine lateral and craniocaudal radiographs were performed of 
both shoulders and elbows in all patients at baseline. Mineralization 
of the affected supraspinatus tendon was noted in eight cases 
(14.5%) (Figure 4A). No other abnormalities were noted.
Magnetic resonance imaging
Magnetic resonance imaging of the shoulder was performed in 31 
of the 55 cases. Of these 31 cases, findings indicative of a ST include 
FigUre 7 | There was a significant difference in cross-sectional area (csa) noted between the injured and contralateral normal supraspinatus 
tendon prior to aDPc-PrP therapy at day 0 (p = 0.002).
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Objective gait analysis
Following ultrasound-guided injection of ADPC-PRP therapy, 
objective gait analysis was available on 25 of the 55 dogs at 90 days 
FigUre 8 | Following treatment, a significant reduction in tendon size 
(csa) was noted in the treated tendon at both 45 and 90 days 
following treatment when compared to the initial csa (p = 0.001; 
p = 0.005).
hyperintensity of signal on T1 and STIR sequences of the ST at its 
insertion on the greater tubercle (Figure 4B). Mineralization can 
also be seen on MRI. A flattened or oval appearance of the biceps 
tendon, loss of fluid around the biceps tendon within the bicipital 
groove at the level of insertion of the supraspinatus, subsequent 
compartmentalization of fluid distal to supraspinatus insertion, 
fatty replacement at the myotendinous junction (seen on T1) 
of the supraspinatus and/or displacement of the biceps tendon 
from the bicipital groove all characterized biceps impingement 
secondary to ST (Figures 4C,D).
Musculoskeletal Diagnostic Ultrasound
Cross-sectional area of the treated (ADPC-PRP injected) tendon 
was compared to the contralateral (non-affected) tendon at base-
line and at 90 days post treatment.
There was a significant difference in CSA noted between the 
injured and contralateral normal supraspinatus tendon prior to 
ADPC-PRP therapy (p = 0.002; Figures 4E and 5). No significant 
difference in CSA was noted between the injured and contralateral 
normal supraspinatus tendon at 45 and 90 days post treatment 
(Figure 5). Following treatment, a significant reduction in tendon 
size (CSA) was noted in the treated tendon at both 45 and 90 days 
following treatment when compared to the initial CSA (p = 0.001; 
p = 0.005; Figures 6 and 7). Reduction in supraspinatus size was 
noted in all cases with 82% of cases reaching the contralateral 
supraspinatus size. All cases showed improvement in fiber pat-
tern of the affected supraspinatus tendon at both 45  and 90 days 
following treatment.
9Canapp Jr. et al. Regenerative Medicine for Supraspinatus Tendinopathy
Frontiers in Veterinary Science | www.frontiersin.org September 2016 | Volume 3 | Article 61
post ADPC-PRP therapy. TPI% of the treated forelimb was com-
pared to the contralateral (non-affected) forelimb at baseline and at 
each follow-up evaluation. Results of objective gait analysis showed 
a significant difference in TPI% between the injured and con-
tralateral normal forelimb prior to injection with the injured limb 
having a lower TPI% (p = 0.014; Figure 8). Following treatment, 
a significant increase in TPI% was noted in the injured (treated) 
forelimb at 90 days post treatment (p = 0.036). At 90 days following 
treatment, 88% of cases had no significant difference in TPI% of the 
injured limb to the contralateral limb (Figures 8 and 9).
DiscUssiOn
Based on the objective gait analysis and diagnostic ultrasound 
results, ADPC-PRP therapy appears to be promising for dogs with 
ST, especially those who have failed to respond to conservative 
management and rehabilitation therapy. Measurable improve-
ment in lameness as indicated by TPI, and in CSA, was seen over 
time and/or in comparison to contralateral normal tendons.
When considering treatment options for ST patients, it is 
important to note that many of the patients failed to respond 
to conservative management prior to presentation as 61.8% of 
patients failed to respond to NSAID therapy and 45.5% failed 
to respond to rehabilitation therapy. This may suggest that con-
servative management is often insufficient to treat ST. While dogs 
treated surgically have been shown to improve in gait and overall 
comfort, regenerative medicine therapy also shows promising 
results and should be considered for dogs with ST. Future studies 
are needed to further evaluate the use of regenerative medicine 
therapy for ST and other tendon injuries in the canine.
Limitations of this study are primarily related to the nature 
of a retrospective study, and the use of a combination therapy. 
Future studies should be randomized, blinded, and controlled. 
While there was no placebo control, 61.8% had previously failed 
to respond to NSAID therapy and 45.5% had previously failed 
rehabilitation therapy. Initially, our group treated refractory 
cases of ST with PRP alone. This treatment in a limited num-
ber of cases subjectively did not seem to improve healing by 
ultrasonographic evaluation, and PRP therapy was abandoned 
in favor of the described ADPC-PRP therapy. In contrast to PRP 
alone, initial cases treated with ADPC/PRP therapy showed 
subjective improvement in both echogenicity and lameness. 
A small pilot study using a leukocyte and platelet-rich plasma 
alone to treat ST in 10 dogs improved lameness and function 
(33). It is possible that other formulations of PRP with higher 
white blood cell and/or platelet concentrations may be more 
efficacious than the leukocyte reduced or pure PRP used in our 
cases (48). It is also possible that PRP treatment has an effect 
on pain, but does not promote remodeling resulting in similar 
ultrasonographic appearance, but improvement in lameness as 
seen in Ho et al.’s study (33). Finally, this study did not include 
immunohistochemistry, immunofluorescence, and histopa-
thology to confirm that the stem cells have differentiated and 
incorporated into the injured tissues. Further studies would be 
needed to definitively prove the differentiation and engraftment 
of the stem cells.
In conclusion, ADCP in combination with PRP may pro-
vide an adequate biologic effect leading to tendon healing and 
improved function. Because of the limited efficacy of current 
non-surgical management, consideration should be given to 
FigUre 9 | The individual cross-sectional area (csa) of the affected supraspinatus tendon at days 0 and 90 and unaffected supraspinatus 
tendon.
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